Tag: Life Sciences

Healthcare & Life Sciences Services Market Insights January 2024

By

2023 included notable M&A activity in the Healthcare & Life Sciences Services market, propelled by ongoing scientific and technological advancement and regulatory changes, and strong interest from private equity investors. Key segments attracting market demand included medical communications, commercialization consulting, regulatory affairs, outsourced drug development services, revenue cycle management, EHR and clinical workflow consulting, and … Continued

Clearsight Advises NMS Capital’s Health & Wellness Partners in its Acquisition of Hybrid Healthcare Communications

By

Clearsight Advisors, Inc. served as the exclusive financial advisor to New MainStream Capital, LLC (“NMS Capital”) and Health & Wellness Partners, LLC (“HWP”) in its acquisition of Hybrid Healthcare Communications, LLC, a leading medical communications solutions firm. The Clearsight deal team included Greg Treger, Tory Steel, Jonathan Holland, and Emily Battle.

Clearsight and Investec Advise Doceree on Capital Raise

By

Clearsight Advisors, Inc. (“Clearsight”) is pleased to announce a cross-border transaction in its Healthcare & Life Sciences practice. Investec plc, in partnership with Clearsight, advised Doceree, Inc. (“Doceree” or the “Company”) on a capital raise led by Creaegis Advisors, LLP (“Creaegis”). Existing investors, Eight Roads Ventures, and F-Prime Capital, also participated in the Series B … Continued

Clearsight Advises Kx Advisors in its Acquisition by BGB Group

By

Clearsight Advisors, Inc. (“Clearsight”) is pleased to announce another successful transaction in its Healthcare & Life Sciences Consulting practice. Clearsight served as the exclusive advisor to Kx Advisors, LLC (“Kx” or the “Company”) in its acquisition by BGB Group, LLC (“BGB”), a portfolio company of Tarrant Capital IP, LLC dba TPG (“TPG”). Kx Advisors is … Continued

Clearsight Advises CREO in its Recapitalization by Grant Avenue Capital

By

Clearsight Advisors, Inc. (“Clearsight”) is proud to announce a successful transaction in its industry-leading Healthcare & Life Sciences practice. Clearsight served as the exclusive financial advisor to CREO, Inc. (“CREO” or the “Company”) in its recapitalization by Grant Avenue Capital, LLC (“Grant Avenue”). CREO is a leading management consultancy serving growing life sciences, healthcare, and … Continued

Clearsight Advises Bionest Partners in its Acquisition by Accenture

By

Clearsight Advisors, Inc. (“Clearsight”) is pleased to share another successful transaction in its Healthcare and Life Sciences Practice. Clearsight served as exclusive financial advisor to Bionest Partners, Inc. (“Bionest” or the “Company”) in its acquisition by Accenture (NYSE: ACN). Bionest is an industry-leading life sciences consulting firm focused on commercialization, go-to-market strategy, and launch execution … Continued

Clearsight Advises Inovalon on the Divestiture of Avalere to Fishawack Health

By

Clearsight Advisors, Inc. (“Clearsight”) is pleased to announce another successful transaction in its Healthcare & Life Sciences practice. Clearsight served as the exclusive financial advisor to Inovalon, Inc. (“Inovalon”) on the divestiture of its healthcare consulting and advisory business, Avalere Health, LLC (“Avalere”), to Fishawack, Ltd. (“Fishawack”), a portfolio company of Bridgepoint Advisers, Ltd. (“Bridgepoint”). … Continued

Clearsight Advises Triangle Insights Group in its Acquisition by TrialCard

By

Clearsight Advisors, Inc. (“Clearsight”) is pleased to announce another successful transaction in its Life Sciences Consulting practice. Clearsight served as the exclusive financial advisor to Triangle Insights Group, LLC (“Triangle” or the “Company”) in its acquisition by TrialCard, Inc. (“TrialCard”), a portfolio company of Odyssey Investment Partners, LLC (“Odyssey”). This transaction reaffirms Clearsight as a … Continued

Clearsight Advises Danforth Advisors on an Investment by Avesi Partners

By

Clearsight Advisors, Inc. (“Clearsight”) is pleased to announce another successful transaction in its Outsourced Finance and Accounting and Life Sciences Consulting practices. Clearsight served as the exclusive financial advisor to Danforth Advisors, LLC (“Danforth” or the “Company”), a portfolio company of Stone-Goff Partners (“Stone-Goff”), on a growth investment by Avesi Partners (“Avesi”). This transaction reaffirms … Continued

Clearsight Advises Huron on the Divestiture of its Life Sciences Business to Oliver Wyman

By

Clearsight Advisors, Inc. is pleased to announce another successful transaction in its Life Sciences Consulting practice. Clearsight served as the exclusive financial advisor to Huron Consulting Group Inc. (“Huron” or the “Company”) (NYSE: HURN) on the divestiture of its life sciences commercial and R&D strategy, pricing and market access strategy business (the “Life Sciences Business”) … Continued

Clearsight Advises ClearView Healthcare Partners in its Recapitalization by GHO Capital

By

Clearsight Advisors, Inc. (“Clearsight”) is pleased to announce another successful transaction in its Life Sciences Consulting practice. Clearsight served as a strategic investment banking advisor to ClearView Healthcare Partners, LLC (“ClearView” or the “Company”) in its recapitalization by GHO Capital Partners, LLP (“GHO Capital”). This transaction underscores Clearsight as the preeminent advisor to strategy consulting … Continued

Clearsight Advises Process Stream in its Acquisition by Sikich

By

Clearsight Advisors, Inc. (“Clearsight”) is pleased to announce another successful transaction in its Life Sciences Consulting and Compliance Practices. Clearsight served as exclusive advisor to Process Stream (or “The Company”) in the acquisition of its assets by Sikich, LLP (“Sikich”). This transaction emphasizes Clearsight’s role as a preeminent advisor to the consulting and compliance sectors. … Continued

Clearsight Advises Cumberland in its Acquisition by Tegria

By

Clearsight Advisors, Inc. (“Clearsight”) is pleased to announce another successful transaction in its market-leading Healthcare & Life Sciences Consulting and Outsourcing Practice. Clearsight served as the exclusive strategic financial advisor to Cumberland Consulting Group, LLC (“Cumberland” or “The Company”), a portfolio company of Tailwind Capital Group, LLC, on its sale to Tegria. This transaction affirms … Continued

Clearsight Advises Deloitte on the Sale of its Life Sciences Pricing and Contracting Solutions Business to Model N

By

Clearsight Advisors, Inc. is pleased to announce that it served as exclusive financial advisor to Deloitte & Touche LLP on the sale of its life sciences pricing and contracting solutions business (PaCS) and underlying technology to Model N, Inc. (NYSE: MODN), which closed on December 31, 2020. The transaction broadens Model N’s portfolio to better serve … Continued

Clearsight Advises RRD International in its Acquisition by Uniphar

By

Clearsight Advisors, Inc. (“Clearsight”) is pleased to announce another successful Life Sciences transaction.  Clearsight served as the exclusive strategic financial advisor to RRD International, LLC (“RRD” or “The Company”) in its acquisition by Uniphar Plc (“Uniphar”). This deal marks Clearsight’s sixth Healthcare/Life Sciences transaction since last summer. RRD is a US-based pharmaceutical advisory group providing … Continued

Clearsight Advises Cumberland on the Sale of its Life Sciences Division to IntegriChain

By

Clearsight Advisors, Inc. (“Clearsight”) is pleased to announce another successful transaction in its market-leading Healthcare & Life Sciences Consulting and Outsourcing Practice. Clearsight served as the exclusive strategic and financial advisor to Cumberland Consulting Group, LLC (“Cumberland”) on the sale of its Life Sciences Division to IntegriChain, Inc., an Accel-KKR portfolio company. This transaction further … Continued

Clearsight Advises Putnam Associates in its Acquisition by UDG Healthcare plc

By

Clearsight Advisors, Inc. (“Clearsight”) is pleased to announce another successful transaction in its market-leading Healthcare Consulting Practice. Clearsight served as the exclusive strategic and financial advisor to Putnam Associates in its acquisition by UDG Healthcare plc’s Ashfield Communications and Advisory business (LON: UDG) (“UDG”). This transaction further emphasizes Clearsight’s position as the leader in advising … Continued

Clearsight Advises SmartAnalyst in its Acquisition by UDG Healthcare plc

By

Clearsight Advisors, Inc. (“Clearsight”) is pleased to announce another successful transaction in its market-leading Healthcare Consulting Practice. Clearsight served as the exclusive strategic and financial advisor to SmartAnalyst in its acquisition by UDG Healthcare plc (LON: UDG) (“UDG”). This transaction further emphasizes Clearsight’s position as the leader in advising high-end consulting firms serving the life … Continued

Water Street Healthcare Partners Acquires Alliance Life Sciences and Health Strategies Group

By

On December 5, 2017, Water Street Healthcare Partners (“Water Street”), a private equity firm focused on investments in the healthcare industry, completed two acquisitions to continue building its life sciences commercialization services platform. The firm acquired Health Strategies Group, a provider of market access intelligence and customized research for pharmaceutical and biotech professionals, and Alliance … Continued

Navigant Expands Life Sciences Practice By Acquiring Quorum Consulting

By

On November 2, 2017, Navigant Consulting, Inc. (NYSE:NCI) (“Navigant”), an independent, global professional services firm, announced that it has acquired substantially all of the assets of Quorum Consulting, Inc. (“Quorum”), a consulting firm focused on life sciences market access, for an undisclosed amount in order to augment its capabilities and methodologies for the life sciences … Continued

Clearsight Advises OpenQ in its Acquisition by Anju Software

By

Clearsight is proud to have advised OpenQ, a provider of identification management software for the life sciences industry, in its acquisition by Anju Software, Inc., a portfolio company of Providence Equity. Financial details of the transaction were not disclosed. For further information about Clearsight’s healthcare and life sciences software expertise, please reach out to Managing … Continued

pdf overview cover Download PDF

Industry insights to your inbox

Subscribe to our newsletters and take your firm to the next level.

Areas of Interest

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.